| Literature DB >> 24673907 |
Tao Chen1, Jian Yan2, Yan Li2.
Abstract
Titanium dioxide nanoparticles (TiO(2)-NPs, <100 nm) are increasingly being used in pharmaceuticals and cosmetics due to the unique properties derived from their small sizes. However, their large surface-area to mass ratio and high redox potential may negatively impact human health and the environment. TiO(2)-NPs can cause inflammation, pulmonary damage, fibrosis, and lung tumors and they are possibly carcinogenic to humans. Because cancer is a disease involving mutation, there are a large number of studies on the genotoxicity of TiO(2)-NPs. In this article, we review the results that have been reported in the literature, with a focus on data generated from the standard genotoxicity assays. The data include genotoxicity results from the Ames test, in vitro and in vivo Comet assay, in vitro and in vivo micronucleus assay, sister chromatid exchange assay, mammalian cell hypoxanthine-guanine phosphoribosyl transferase gene assay, the wing somatic mutation and recombination assay, and the mouse phosphatidylinositol glycan, class A gene assay. Inconsistent results have been found in these assays, with both positive and negative responses being reported. The in vitro systems for assessing the genotoxicity of TiO(2)-NPs have generated a greater number of positive results than the in vivo systems, and tests for DNA and chromosome damage have produced more positive results than the assays measuring gene mutation. Nearly all tests for measuring the mutagenicity of TiO(2)-NPs were negative. The current data indicate that the genotoxicity of TiO(2)-NPs is mediated mainly through the generation of oxidative stress in cells.Entities:
Keywords: Ames test; Carcinogenicity; Class A gene; Comet; Genotoxicity; Hypoxanthine-guanine phosphoribosyl transferase gene; Micronucleus; Phosphatidylinositol glycan; Sister chromatid exchange; Titanium dioxide nanoparticles; Wing point mutation
Mesh:
Substances:
Year: 2014 PMID: 24673907 PMCID: PMC9359145 DOI: 10.1016/j.jfda.2014.01.008
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
In vitro studies on genotoxicity of titanium dioxide nanoparticles.
| Size and crystalline structure | Dose | Test system | Result | Author and Reference |
|---|---|---|---|---|
|
| ||||
| 23 nm; 84% anatase and 16% rutile | 1–100 μg/mL | A modified fluctuation test procedure for the Ames test | Positive | Jomini et al, 2012 [ |
| 5.7 nm; 86% anatase and 14% brookite | 1–100 μg/mL | A modified fluctuation test procedure for the Ames test | Positive | Jomini et al, 2012 [ |
| 23 nm; 84% anatase and 16% rutile | 1–100 μg/mL | Fluctuation Ames test | Negative | Jomini et al, 2012 [ |
| 5.7 nm; 86% anatase and 14% brookite | 1–100 μg/mL | Fluctuation Ames test | Negative | Jomini et al, 2012 [ |
| 10 × 50 nm; rutile in T-Lite | Up to 5 mg/plate | Ames test | Negative | Landsiedel et al, 2010 [ |
| 10 nm; anatase | 5 mg/plate | Ames test | Negative | Woodruff et al, 2012 [ |
|
| ||||
| <25 nm; anatase | 50 μg/mL and 100 μg/mL | Bottlenose dolphin leukocytes | Positive | Bernardeschi et al, 2010 [ |
| 21 nm; 80%/20% anatase/rutile | 150 mg/mL | AGS human gastric epithelial cell line | Positive | Botelho et al, 2013 [ |
| 2.3 nm | 100 μg/mL | With or without Fpg and End III in Human peripheral blood lymphocytes and cultured human embryonic kidney cells (HEK293) | Positive | Demir et al, 2013a [ |
| 50 nm | 25 μg/mL | Human lymphocytes | Positive | Ghosh et al, 2013 [ |
| 14 nm; anatase | 50 μg/mL | Syrian hamster embryo cells | Positive | Guichard et al, 2012 [ |
| 25 nm; 80%/20% anatase/rutile | 10 μg/mL, 25 μg/mL, and 50 μg/mL | Syrian hamster embryo cells | Positive | Guichard et al, 2012 [ |
| 5.9 nm; anatase | 100 mg/mL | Chinese hamster lung fibroblast cells | Positive | Hamzeh and Sunahara, 2013 [ |
| 34.1 nm; 83% anatase and 17% rutile | 100 mg/mL | Chinese hamster lung fibroblast cells | Positive | Hamzeh and Sunahara, 2013 [ |
| 1.5 nm; rutile | 100 mg/mL | Chinese hamster lung fibroblast cells | Positive | Hamzeh and Sunahara, 2013 [ |
| Varying sizes 12–140 nm; anatase or rutile | 100 μg/mL | A549 human lung carcinoma cells | Positive | Jugan et al, 2012 [ |
| 7 nm anatase or 10 nm rutile | 0.5–256 μg/mL | Human hepatoblastoma C3A cells | Positive | Kermanizadeh et al, 2012 [ |
| 27.5 nm; 86% anatase/14% rutile | 20–100 μg/mL | Human bronchial epithelial cell | Positive | Prasad et al, 2013 [ |
| 30 nm | 20 μg/mL | Human amnion epithelial (WISH) cells | Positive | Saquib et al, 2012 [ |
| 10 nm; anatase | 0.8–80 μg/mL | Human epidermal cells (A431) | Positive | Shukla et al, 2011 [ |
| 30–70 nm | 1–80 μg/mL | HepG2 cells | Positive | Shukla et al, 2013 [ |
| <100 nm | 3μM, 5 μM, and 10 μM | Human peripheral blood lymphocytes | Positive | Turkez 2011 [ |
| 25 nm anatase; 25 nm 80% anatase and 20% rutile | 80 μg/mL, 120 μg/mL, and 150 μg/mL | Human SHSY5Y neuronal cells | Positive | Valdiglesias et al, 2013 [ |
| <100 nm anatase | Up to 50 μg/cm2 | Human lung fibroblasts and human bronchial fibroblasts | Negative | Bhattacharya et al, 2009 [ |
| 62 nm; rutile | Up to 50 μg/mL | Syrian hamster embryo cells | Negative | Guichard et al, 2012 [ |
| 15–30 nm; anatase | 20–200 μg/mL | Human peripheral blood lymphocytes | Negative | Hackenberg et al, 2011 [ |
| 1–10 nm; polyacrylate-coated | 100 mg/mL | Chinese hamster lung fibroblast cells | Negative | Hamzeh and Sunahara, 2013 [ |
| 10 × 50 nm; rutile in T-Lite | Up to 600 μg/mL for 4 h exposure and up to 150 μg/mL for 24 h exposure | V79 cells | Negative | Landsiedel et al, 2010 [ |
| 10 nm; anatase | Up to 40 μg/mL | Chinese hamster ovary cells (CHO-K1) | Negative | Wang et al, 2011 [ |
| 10 nm; anatase | Up to 200 μg/mL | TK6 human lymphocytes | Negative | Woodruff et al, 2012 [ |
|
| ||||
| 20 nm | 0.5 μg/mL and 1 μg/mL | Chinese hamster ovary cells | Positive | Di Virgilio et al, 2010 [ |
| 27.5 nm; 86% anatase/14% rutile | 20–100 μg/mL | Human bronchial epithelial cell | Positive | Prasad et al, 2013 [ |
| ≤20 nm | 1.0 μg/cm2 | Syrian hamster embryo cells | Positive | Rahman et al, 2002 [ |
| 30–70 nm | 1–80 μg/mL | HepG2 cells | Positive | Shukla et al, 2013 [ |
| 10 nm; anatase | 0.8–80 μg/mL | Human epidermal cells (A431) | Positive | Shukla et al, 2011 [ |
| <25 nm | 10 and 50 μg/mL | Human lung cancer cells (A549) | Positive | Srivastava et al, 2011 [ |
| 21 nm; anatase; | 5–125 μg/mL | Human lymphocytes | Positive | Tavares et al, 2013 [ |
| 22 nm; hydrophobic rutile | 5–125 μg/mL | Human lymphocytes | Positive | Tavares et al, 2013 [ |
| 19 nm; hydrophilic rutile | 5–125 μg/mL | Human lymphocytes | Positive | Tavares et al, 2013 [ |
| <100 nm | 3 μM, 5 μM, and 10 μM | Human peripheral blood lymphocytes | Positive | Turkez, 2008 [ |
| 25 nm; anatase | 80 μg/mL, 120 μg/mL, and 150 μg/mL | Human SHSY5Y neuronal cells | Positive | Valdiglesias et al, 2013 [ |
| 25 nm; 80% anatase and 20% rutile | 80 μg/mL, 120 μg/mL, and 150 μg/mL | Human SHSY5Y neuronal cells | Positive | Valdiglesias et al, 2013 [ |
| 25 nm; 80% anatase and 20% rutile | Up to 50 μg/mL | Syrian hamster embryo cells | Negative | Guichard et al, 2012 [ |
| 14 nm; anatase | Up to 50 μg/mL | Syrian hamster embryo cells | Negative | Guichard et al, 2012 [ |
| 62 nm; rutile | Up to 50 μg/mL | Syrian hamster embryo cells | Negative | Guichard et al, 2012 [ |
| 20 nm; 85% anatase and 15% rutile | Up to 250 μg/mL | Human lymphocytes | Negative | Tavares et al, 2013 [ |
|
| ||||
| 20 nm | 1–5 μg/mL | Chinese hamster ovary cells | Positive | Di Virgilio et al, 2010 [ |
| <100 nm | 3μM, 5 μM and 10μM | Human peripheral blood lymphocytes | Positive | Turkez, 2008 [ |
|
| ||||
| 10 nm; anatase | Up to 40 μg/mL | Negative | Wang et al, 2011 [ | |
In vivo studies on genotoxicity of titanium dioxide nanoparticles.
| Size and crystalline structure | Dose | Test system | Result | Reference |
|---|---|---|---|---|
|
| ||||
| 33 nm | 40–1000 mg/kg | CBAB6F1 mice were gavaged daily for 7 d, and their bone marrow, liver and brain were assayed | Positive in bone marrow and liver; negative in brain | Sycheva et al, 2011 [ |
| 21 nm; 75% anatase and 25% rutile | 500 mg/kg | Mice were exposed via drinking water for 5 d, and their blood cells were used for the assay | Positive | Trouiller et al, 2009 [ |
| 80 nm; 74% anatase and 26% brookite | Up to 28.5 mg/m3 | Rats were exposed via inhalation for 5 d, 4 h/d and their lung cells were assayed | Negative | Lindberg et al, 2012 [ |
| 10 × 50 nm; rutile in T-Lite | 10 mg/kg | Rats were exposed by inhalation, and their lung cells were assayed | Negative | Landsiedel et al, 2010 [ |
| 5 nm; anatase | Up to 5 mg/kg | Intratracheally exposure to male Sprague–Dawley rats, and the lung cells was assayed | Negative | Naya et al, 2012 [ |
|
| ||||
| 21 nm; 75% anatase and 25% rutile | 500 mg/kg | Mice were exposed via drinking water for 5 d. The mouse blood cells were tested | Positive | Trouiller et al, 2009 [ |
| 80 nm; 74% anatase and 26% brookite | Up to 28.5 mg/m3 | Rats were exposed via inhalation for 5 d, 4 h/d. The peripheral blood polychromatic erythrocytes were tested | Negative | Lindberg et al, 2012 [ |
| 10 nm; anatase | Three daily dose of 50 mg/kg | Intravenously exposure to male B6C3F1 mice; the blood cells was assayed | Negative | Sadiq et al, 2012 [ |
| 40 nm; anatase | Up to 1387 mg/kg | One dose intravenous injection to mice, and the blood cells were assayed | Negative | Xu et al, 2013 [ |
|
| ||||
| 2.3 nm; anatase | Fed, 0.1–10 mM | Negative | Demir et al, 2013b [ | |
| 10 nm; anatase | Three daily dose of 50 mg/kg | Intravenously exposure to male B6C3F1 mice and | Negative | Sadiq et al, 2012 [ |